However, this seemingly paradoxical function of DDX5 provides the ideal situation when targeting DDX5 for cancer therapeutics as it provides the ability to potentially avoid adverse side effects on physiology and normal tissues while causing cancer cell death. The gene discussed is DDX5; the disease is cancer.